Stephen Mordue

Title: Innovations by Stephen Mordue

Introduction

Stephen Mordue is an accomplished inventor based in Kirkland, WA (US). He has made significant contributions to the field of nucleic acid assays, holding a total of 3 patents. His work focuses on developing integrated microfluidic cartridges that enhance the detection and analysis of clinical samples.

Latest Patents

Mordue's latest patents include innovations in integrated nucleic acid assays. These patents describe integrated microfluidic cartridges designed for nucleic acid extraction, amplification, and detection from clinical samples. The devices are characterized as single-entry, sanitary, and disposable. They enable both simplex and multiplex nucleic acid target detection, which can be utilized in assay panels for multiple infectious agents or for identifying various cancerous cell types. Additionally, the patents disclose methods for using these microfluidic cartridges in a fully automated, pneumatically controlled apparatus.

Career Highlights

Throughout his career, Stephen Mordue has worked with notable companies such as Micronics, Inc. and PerkinElmer Health Sciences, Inc. His experience in these organizations has contributed to his expertise in the development of innovative medical devices.

Collaborations

Mordue has collaborated with professionals like C Frederick Battrell and John Gerdes, further enhancing his work in the field of medical technology.

Conclusion

Stephen Mordue's contributions to the field of nucleic acid assays through his innovative patents and career experiences highlight his role as a significant inventor in medical technology. His work continues to impact the detection and analysis of clinical samples, paving the way for advancements in healthcare.